Citation Impact
Citing Papers
ASL mRNA-LNP Therapeutic for the Treatment of Argininosuccinic Aciduria Enables Survival Benefit in a Mouse Model
2023 StandoutNobel
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Neonatal Systemic AAV Induces Tolerance to CNS Gene Therapy in MPS I Dogs and Nonhuman Primates
2015
Superior In vivo Transduction of Human Hepatocytes Using Engineered AAV3 Capsid
2016 StandoutNobel
In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy
2016
AAV9-mediated telomerase activation does not accelerate tumorigenesis in the context of oncogenic K-Ras-induced lung cancer
2018
Risk factors for hepatitis C virus infection in United States blood donors
2000
Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines
2013 StandoutNobel
On-tissue spatially resolved glycoproteomics guided by N-glycan imaging reveal global dysregulation of canine glioma glycoproteomic landscape
2021 StandoutNobel
Gene therapy for neurological disorders: progress and prospects
2018
Heterosexual Transmission of Hepatitis C, Hepatitis B, and HIV-1 in a Sample of Inner-City Women
2000
Rising Incidence of Hepatocellular Carcinoma in the United States
1999 Standout
Tattoos and body piercings in the United States: A national data set
2006 Standout
Aifm2, a NADH Oxidase, Supports Robust Glycolysis and Is Required for Cold- and Diet-Induced Thermogenesis
2020
Hallmarks of aging: An expanding universe
2023 Standout
Understanding normal development of adolescent sexuality: A bumpy ride
2015 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Epidemiology of hepatitis C
1997 Standout
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
Hepatitis C Virus Infection in Chicago Women With or at Risk for HIV Infection
1998
Seroprevalence of hepatitis C virus nucleocapsid antibodies in patients with cryptogenic chronic liver disease
1992
PROSPECTS FOR A HEPATITIS C VIRUS VACCINE
1999 StandoutNobel
High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C
1998 StandoutNobel
CD4 T Lymphocyte Proliferative Responses to Hepatitis C Virus (HCV) Antigens in Patients Coinfected with HCV and Human Immunodeficiency Virus Who Responded to Anti‐HCV Treatment
2002 StandoutNobel
Systemic AAV9 gene transfer in adult GM1 gangliosidosis mice reduces lysosomal storage in CNS and extends lifespan
2015
Reciprocal Interactions Between Human Immunodeficiency Virus and Hepatitis C Virus Infections
1996
Perspectives for a vaccine against hepatitis C virus
1999 StandoutNobel
Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection
2010
HCV epidemiology in high-risk groups and the risk of reinfection
2016
Adeno-associated virus vector as a platform for gene therapy delivery
2019 Standout
Commercial Tattooing as a Potentially Important Source of Hepatitis C Infection
2001
Detection of hepatitis C virus-specific antigens in semen from non-A, non-B hepatitis patients
1992
Hospital safety climate and its relationship with safe work practices and workplace exposure incidents
2000 Standout
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Strategies and Prospects for Vaccination Against the Hepatitis C Viruses
2000 StandoutNobel
Emerging Issues in AAV-Mediated In Vivo Gene Therapy
2017
Hepatitis B and Hepatitis C in Emergency Department Patients
1992
Infrequent Vertical Transmission of Hepatitis C Virus
1993
Advances in Diagnostic and Treatment Modalities for Intracranial Tumors
2014
Copackaged AAV9 Vectors Promote Simultaneous Immune Tolerance and Phenotypic Correction of Pompe Disease
2015
Direct Intracranial Injection of AAVrh8 Encoding Monkey β-N-Acetylhexosaminidase Causes Neurotoxicity in the Primate Brain
2017
Adeno-Associated Virus-Based Gene Therapy for CNS Diseases
2016
Evaluation of Hepatitis C Virus Glycoprotein E2 for Vaccine Design: an Endoplasmic Reticulum-Retained Recombinant Protein Is Superior to Secreted Recombinant Protein and DNA-Based Vaccine Candidates
2000 StandoutNobel
Erratum: Gene therapy for neurological disorders: progress and prospects
2018
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Hepatitis C virus infection among a cohort of Victorian injecting drug users
1993
Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus
1994 StandoutNobel
The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002
2006 Standout
A GLP-Compliant Toxicology and Biodistribution Study: Systemic Delivery of an rAAV9 Vector for the Treatment of Mucopolysaccharidosis IIIB
2015
Sexual Behavior and Selected Health Measures: Men and Women 15-44 Years of Age, United States, 2002
2005 Standout
The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter study
1992
Cationic microparticles are a potent delivery system for a HCV DNA vaccine
2004 StandoutNobel
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Antibody response to core, envelope and nonstructural hepatitis C virus antigens: Comparison of immunocompetent and immunosuppressed patients
1993 StandoutNobel
Oral sex and the transmission of viral STIs
1998
Telomerase gene therapy rescues telomere length, bone marrow aplasia, and survival in mice with aplastic anemia
2016
Overcoming the Host Immune Response to Adeno-Associated Virus Gene Delivery Vectors: The Race Between Clearance, Tolerance, Neutralization, and Escape
2017
Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trial.
1997
Works of Albert Ribera being referenced
Biochemical, histological and functional correction of mucopolysaccharidosis Type IIIB by intra-cerebrospinal fluid gene therapy
2014
Liver Production of Sulfamidase Reverses Peripheral and Ameliorates CNS Pathology in Mucopolysaccharidosis IIIA Mice
2011
Correction of Pathological Accumulation of Glycosaminoglycans in Central Nervous System and Peripheral Tissues of MPSIIIA Mice Through Systemic AAV9 Gene Transfer
2012
Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy
2013
Sexual transmission of hepatitis C virus and its relation with hepatitis B virus and HIV.
1990
In Vivo Adeno-Associated Viral Vector–Mediated Genetic Engineering of White and Brown Adipose Tissue in Adult Mice
2013